COPENHAGEN Novo Nordisk will launch its hugely popular anti-obesity drug Wegovy in Japan on Feb. 22 next year, its first launch in Asia, the company said on Thursday, even as it struggles to keep up with demand in existing markets.
COPENHAGEN (Reuters) -Novo Nordisk will launch its hugely popular anti-obesity drug Wegovy in Japan on Feb. 22 next year, its first launch in Asia, the company said on Thursday, even as it struggles to keep up with demand in existing markets. The Danish company has picked Japan as the sixth country in which to launch Wegovy despite obesity being a much smaller problem in the Asian country relative to Western countries. Most patients in Japan will pay 30% of medical expenses for Wegovy, in line w
Novo to launch Wegovy in Asia with February Japan roll-out devdiscourse.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from devdiscourse.com Daily Mail and Mail on Sunday newspapers.
COPENHAGEN : Novo Nordisk will launch its hugely popular anti-obesity drug Wegovy in Japan on Feb. 22, its first launch in Asia, the company said on Thursday, even as it struggles to keep up with demand in existing markets.The Danish company has picked Japan as the sixth country in which to launch Wegovy
Novo to launch anti-obesity drug Wegovy in Asia with February Japan roll-out japantoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from japantoday.com Daily Mail and Mail on Sunday newspapers.